|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's Range||286.19 - 294.26|
|52 Week Range||195.91 - 309.60|
|Beta (5Y Monthly)||1.01|
|PE Ratio (TTM)||10.83|
|Earnings Date||Feb 09, 2022 - Feb 14, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Mar 29, 1994|
|1y Target Est||327.86|
Investors are optimistic about Boston Scientific (BSX) owing to its solid third-quarter performance and impressive value-added acquisitions.
Labcorp now offers observed self-collection for its Covid-19 PCR testing at over 500 of its patient service centers, with plans to expand to more than 1,000 locations by mid-December.
NextGen (NXGN) continues to gain momentum on the back of solid demand for its solutions and strength in EHR.